AGEN : Analysis & Opinions

  1. Clinical Trial Hopes Drugs Help Body Fight Cancer

    January 18, 2017
    Agenus will begin a study that pairs a personalized cancer vaccine with Merck's PD-1 pathway blocker.
  2. Agenus 3Q Loss $41M, or 47 Cents a Share (AGEN)

    October 28, 2016
    Agenus posted a 3Q loss of $41 million, or 47 cents a share, worse than Wall Street estimates.
  3. The Top 5 Health Care Penny Stocks for 2016 (CRIS, GERN)

    January 20, 2016
    Discover why the health care industry is a good play for investors and learn key information about the top five health care ...